Treatment preferences among patients with mild-to-moderate atopic dermatitis
Study purpose: New treatments for atopic dermatitis (AD) are emerging; however, little is known about the treatment preferences of patients with mild-to-moderate AD. To measure patients' preferences, a cross-sectional, web-based discrete choice experiment (DCE) survey was developed and administ...
Saved in:
Main Authors: | Kelley Myers (Author), Jonathan I. Silverberg (Author), Shreekant Parasuraman (Author), Anna Pierce (Author), Lawrence F. Eichenfield (Author), Christine Poulos (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
by: Eric L. Simpson, et al.
Published: (2018) -
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024) -
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
by: Joseph Fowler, et al.
Published: (2023) -
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis
by: Lawrence F. Eichenfield, et al.
Published: (2024) -
Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
by: Mahreen Ameen, et al.
Published: (2024)